COMPLEMENT REGULATION IN THE RAT GLOMERULUS - CRRY AND CD59 REGULATE COMPLEMENT IN GLOMERULAR MESANGIAL AND ENDOTHELIAL-CELLS

被引:48
|
作者
QUIGG, RJ
MORGAN, BP
HOLERS, VM
ADLER, S
SNEED, AE
LO, CF
机构
[1] UNIV WALES COLL MED,DEPT MED BIOCHEM,CARDIFF CF4 4XN,S GLAM,WALES
[2] UNIV COLORADO,HLTH SCI CTR,DEPT MED,DIV RHEUMATOL,DENVER,CO 80262
[3] NEW YORK MED COLL,DEPT MED,DIV NEPHROL,VALHALLA,NY 10595
[4] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT INTERNAL MED,DIV NEPHROL,RICHMOND,VA 23298
基金
英国惠康基金;
关键词
D O I
10.1038/ki.1995.309
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The complement regulators, decay accelerating factor, membrane cofactor protein, and CD59 are present in human glomeruli. Crry is the rodent analogue to the former two proteins. In this study, we examined complement regulation in cultured rat glomerular endothelial cells (GEnC) and mesangial cells (MES). Immunoprecipitation of I-125-labeled membrane proteins and Western blotting studies were performed with anti-Crry and anti-CD59. In both GEnC and MES, Crry was present as 53, 65, and 78 kD proteins. The 20 kD CD59 was apparent in GEnC. CD59 was, also present in MES, but in relatively smaller quantities. By Northern analyses, 1.8 kb CD59 mRNA was present in GEnC as well as in RNA from isolated rat glomeruli. mRNA for Crry was present in both GEnC and MES as 2.2 kb species. The functional significance of these proteins was evaluated next. Anti-Thy 1.1 IgG was used to activate the complement classical pathway in MES. To inhibit the function of the complement regulators, anti-CD59 and/or anti-Crry F(ab')(2) antibodies were added with anti-Thy 1.1. Inhibition of Crry function led to enhanced cytotoxicity, while there was no effect when CD59 function was inhibited. The complement alternative pathway was studied by adding complement in Mg-EGTA buffer. Inhibition of Crry led to productive alternative pathway activation, which was accentuated by anti-CD59 when Crry was incompletely inhibited. Alternative pathway regulation was also evaluated in GEnC. Inhibition of CD59 function alone had no effect in GEnC, while inhibition of Crry led to significant cytotoxicity from alternative pathway activation. Under conditions in which Crry was inactive, inhibition of CD59 further enhanced cytotoxicity. Therefore, Crry is present in both GEnC and MES and restricts the complement alternative pathway in both cell types. Crry also regulates the classical pathway in MES. CD59 is present and functionally active in GEnC, while it appears to have a minor role in MES.
引用
收藏
页码:412 / 421
页数:10
相关论文
共 50 条
  • [41] Cell surface regulators of complement, 512 antigen, and CD59, in the rat eye and adnexal tissues
    Bardenstein, DS
    Cheyer, C
    Okada, N
    Morgan, BP
    Medof, ME
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (02) : 519 - 524
  • [42] EXPRESSION AND REGULATION OF THE MEMBRANE-ASSOCIATED COMPLEMENT-REGULATORS CD46, CD55 AND CD59 IN GASTROINTESTINAL CELLS
    SCHMITT, C
    SCHWAEBLE, W
    WITTIG, B
    ZUMBUSCHENFELDE, KHM
    DIPPOLD, W
    GASTROENTEROLOGY, 1994, 106 (04) : A768 - A768
  • [43] ERYTHROID-SPECIFIC EXPRESSION OF HUMAN CD59 AND TRANSFER TO VASCULAR ENDOTHELIAL-CELLS
    KOOYMAN, D
    BYRNE, G
    MCCLELLAN, S
    NIELSEN, D
    KAGAN, D
    COFFMAN, T
    MASAHIDE, T
    WALDMANN, H
    PLATT, J
    LOGAN, J
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (03) : 1241 - 1241
  • [44] Increased internalization of complement inhibitor CD59 may contribute to endothelial inflammation in obstructive sleep apnea
    Emin, Memet
    Wang, Gang
    Castagna, Francesco
    Rodriguez-Lopez, Josanna
    Wahab, Romina
    Wang, Jing
    Adams, Tessa
    Wei, Ying
    Jelic, Sanja
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (320)
  • [45] TRANSFECTION OF HUMAN CD59 COMPLEMENTARY-DNA INTO RAT-CELLS CONFERS RESISTANCE TO HUMAN-COMPLEMENT
    WALSH, LA
    TONE, M
    WALDMANN, H
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (03) : 847 - 850
  • [46] Expression of heterologous CD59 and CRRY protects human breast cancer cells from anti-MUC-1 directed complement-mediated lysis
    Caragine, T
    Chen, S
    Frey, A
    Tomlinson, S
    MOLECULAR IMMUNOLOGY, 1998, 35 (6-7) : 337 - 337
  • [47] Selective expression of the complement regulator CD59 on the NT2-N neuronal cells
    Pedersen, ED
    Froyland, E
    Pharo, AM
    Lindstad, J
    Rootwelt, T
    Mollnes, TE
    MOLECULAR IMMUNOLOGY, 2006, 43 (1-2) : 156 - 156
  • [48] Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro
    Geis, N.
    Zell, S.
    Rutz, R.
    Li, W.
    Giese, T.
    Mamidi, S.
    Schultz, S.
    Kirschfink, M.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (08) : 922 - 931
  • [49] Reduction of complement regulator CD59 expression on human kidney cells by Shiga toxin 2
    Ehrlenbach, Silvia
    Rosales, Alejandra
    Orth, Dorothea
    Wuerzner, Reinhard
    IMMUNOBIOLOGY, 2012, 217 (11) : 1198 - 1199
  • [50] Specific siRNA Targeting of the Membrane Complement Regulator CD59 with Herceptin® Immunoliposomes Sensitize Breast Carcinoma Cells to Complement Mediated Cytotoxicity
    Mamidi, Srinivas
    Gies, Nicolas
    Kirschfink, Michael
    Li, Wenhan
    CLINICAL IMMUNOLOGY, 2010, 135 : S55 - S56